Article Text

PDF

Type IV renal tubular acidosis and spironolactone therapy in the elderly.
  1. J. E. O'Connell,
  2. N. R. Colledge
  1. Geriatric Medicine Unit, University of Edinburgh, City Hospital, UK.

    Abstract

    Spironolactone therapy is a well-known cause of hyperkalaemia, but in susceptible patient, it may also be associated with metabolic acidosis. We report a case of severe renal tubular acidosis (Type IV) with life-threatening hyperkalaemia caused by spironolactone, and discuss the mechanisms by which this may occur.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.